Romidepsin

Overview

Romidepsin is a cyclic peptide inhibitor of histone deacetylase, used in the treatment of various types of cancer, including cutaneous T-cell lymphoma. It works by increasing the acetylation of histone proteins, leading to cell cycle arrest and apoptosis in cancer cells.

API suppliers (2)

Suppliers of Romidepsin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CONCORD BIOTECH LTD1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China

Therapeutic areas